Potential clinical application of LCZ696 in patients with chronic heart failure in real life clinical practice: results from TREAT HF Study

被引：0
|
作者：
Cavusoglu, Y. [1 ]
Eraslan, S. [1 ]
Kaya, H. [2 ]
机构：
[1] Eskisehir Osmangazi Univ, Eskisehir, Turkey
[2] Cumhuriyet Univ, Cardiol, Sivas, Turkey
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1124
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [21] First Experience with Concomitant AT1 and Neprilysin (NEP 24.11) Inhibition with LCZ696 in Patients with Chronic Heart Failure
    Kobalava, Zhanna
    Pavlikova, Elena
    Averkov, Oleg
    Moiseev, Valentin
    Albrecht, Diego
    Feng, Aimen
    Chandra, Priyamvada
    Jordaan, Pierre J.
    CIRCULATION, 2010, 122 (21)
  • [22] Überlegenheit des neuen Wirkstoffs LCZ696 gegenüber Enalapril bei der Behandlung der systolischen HerzinsuffizienzPARADIGM-HF-StudieSuperiority of the new agent LCZ696 for treatment of systolic heart failure compared to enalaprilPARADIGM-HF study
    C. Özcelik
    Der Kardiologe, 2014, 8 (6): : 443 - 445
  • [23] Chronic Heart Failure: Clinical Guidelines and Real Clinical Practice
    Shavarova, Elena K.
    Babaeva, Lala A.
    Padaryan, Sergey S.
    Soseliya, Nino N.
    Lukina, Olga I.
    Milto, Anna S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (06) : 631 - 637
  • [24] Reduction in 30-day Rehospitalization After Discharge From a Heart Failure Admission in Patients Receiving LCZ696 versus Enalapril: PARADIGM-HF
    Solomon, Scott D.
    Packer, Milton
    Zile, Michael
    Rouleau, Jean
    Swedberg, Karl
    Desai, Akshay
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John J.
    CIRCULATION, 2015, 132
  • [25] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN (FORMERLY LCZ696) IN CHRONIC HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION - AN ANALYSIS FOR SWITZERLAND
    Ademi, Z.
    Hancock, E.
    Trueman, D.
    Pfeil, A.
    Haroun, R.
    Deschaseaux, C.
    Schwenkglenks, M.
    VALUE IN HEALTH, 2016, 19 (07) : A655 - A655
  • [26] REMOTE MONITORING IN PATIENTS WITH CHRONIC HEART FAILURE IN REAL CLINICAL PRACTICE
    Nasonova, S. N.
    Lapteva, A. E.
    Zhirov, I., V
    Tereshchenko, S. N.
    Boytsov, S. A.
    KARDIOLOGIYA, 2021, 61 (08) : 76 - 86
  • [27] Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study
    Tsutsui, Hiroyuki
    Momomura, Shinichi
    Saito, Yoshihiko
    Ito, Hiroshi
    Yamamoto, Kazuhiro
    Ohishi, Tomomi
    Okino, Naoko
    Guo, Weinong
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 225 - 231
  • [28] Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study)
    Shaddy, Robert
    Canter, Charles
    Halnon, Nancy
    Kochilas, Lazaros
    Rossano, Joseph
    Bonnet, Damien
    Bush, Christopher
    Zhao, Ziqiang
    Kantor, Paul
    Burch, Michael
    Chen, Fabian
    AMERICAN HEART JOURNAL, 2017, 193 : 23 - 34
  • [29] Resting Heart Rate and effects of beta blocker therapy in real life clinical practice: Results from REALITY HF Study
    Cavusoglu, Y.
    Kozan, O.
    Kucukoglu, S.
    Temizhan, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 158 - 158
  • [30] Implementing clinical trial results into clinical practice for patients with heart failure
    Kim, TC
    Rodeheffer, RJ
    Kopecky, SL
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (05): : 581 - 582
12345